| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular Biology |
From the Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 541 (L.L., C.D., D.Y., D.H.), Paris, France; the Department of Physiology, AP-HP-Hôpital Lariboisière (B.L.), Paris, France; and the Laboratoire de Biologie Moléculaire de la Différentiation (Z.L., D.P.), Paris VII University, Paris, France.
Correspondence to Dr. Laurent Loufrani, PhD, Laboratoire de Physiologie, Faculté de Médecine, Rue Haute de Reculée, 49045 Angers, France. E-mail Laurent.loufrani{at}wanadoo.fr
Objectives Mutations in the dystrophin gene causing Duchennes muscular dystrophy (DMD) lead to premature stop codons. In mice lacking dystrophin (mdx mice), a model for DMD, these mutations can be suppressed by aminoglycosides such as gentamicin. Dystrophin plays a role in flow (shear stress)-mediated endothelium-dependent dilation (FMD) in arteries. We investigated the effect of gentamicin on vascular contractile and dilatory functions, vascular structure, and density in mdx mice.
Methods and Results Isolated mice carotid and mesenteric resistance arteries were mounted in arteriographs allowing continuous diameter measurements. Mdx mice showed lower nitric oxide (NO)-dependent FMD and endothelial NO synthase (eNOS) expression as well as decreased vascular density in gracilis and cardiac muscles compared with control mice. Treatment with gentamycin restored these parameters. In contrast, smooth muscledependent contractions as well as endothelium-dependent or -independent dilation were not affected by dystrophin deficiency or by gentamicin treatment.
Conclusion Dystrophin deficiency induces a selective defect in flow-dependent mechanotransduction, thus attenuating FMD and eNOS expression, and may contribute to low arteriolar density. These findings open important perspectives regarding the mechanism involved in the pathophysiology of genetic diseases related to premature stop codons such as DMD.
Key Words: Duchennes muscular dystrophy blood vessels flow-mediated dilation endothelium vasodilation arteriolar density
This article has been cited by other articles:
![]() |
L. Du, R. Damoiseaux, S. Nahas, K. Gao, H. Hu, J. M. Pollard, J. Goldstine, M. E. Jung, S. M. Henning, C. Bertoni, et al. Nonaminoglycoside compounds induce readthrough of nonsense mutations J. Exp. Med., September 28, 2009; 206(10): 2285 - 2297. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Dye, R. L. Gleason, E. Wilson, and J. D. Humphrey Altered biomechanical properties of carotid arteries in two mouse models of muscular dystrophy J Appl Physiol, August 1, 2007; 103(2): 664 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Heydemann and E. M. McNally Regenerating More Than Muscle in Muscular Dystrophy Circulation, November 23, 2004; 110(21): 3290 - 3292. [Full Text] [PDF] |
||||
![]() |
S. Straino, A. Germani, A. Di Carlo, D. Porcelli, R. De Mori, A. Mangoni, M. Napolitano, F. Martelli, P. Biglioli, and M. C. Capogrossi Enhanced Arteriogenesis and Wound Repair in Dystrophin-Deficient mdx Mice Circulation, November 23, 2004; 110(21): 3341 - 3348. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |